Fibroblast Growth Factors in Cardiovascular Disease.

Autor: Morita H; Department of Cardiology, Osaka Medical and Pharmaceutical University., Hoshiga M; Department of Cardiology, Osaka Medical and Pharmaceutical University.

Publikováno v: Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2024 Nov 01; Vol. 31 (11), pp. 1496-1511. Date of Electronic Publication: 2024 Aug 22.

Prognostic impact of a reduction in the fibrosis-4 index among patients hospitalized with acute heart failure.

Autor: Maeda D; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan. daichimaeda0424@yahoo.co.jp.; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. daichimaeda0424@yahoo.co.jp., Kanzaki Y; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Sakane K; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Tsuda K; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.; Department of Cardiology, Hokusetsu General Hospital, Osaka, Japan., Akamatsu K; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Hourai R; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Okuno T; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Tokura D; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Hasegawa HT; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Morita H; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Ito T; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan., Hoshiga M; Department of Cardiology, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 5698686, Japan.

Publikováno v: Heart and vessels [Heart Vessels] 2023 Oct; Vol. 38 (10), pp. 1235-1243. Date of Electronic Publication: 2023 Jun 06.

Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers.

Autor: Sasaki S; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Ota K; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan. clash_kaz@yahoo.co.jp., Sanomura M; Department of Gastroenterology, Hokusetsu General Hospital, Takatsuki, Osaka, Japan., Mori Y; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Tanaka H; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Hakoda A; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Sugawara N; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Iwatsubo T; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Hirata Y; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Kakimoto K; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Morita H; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Nagamatsu W; Department of Cardiology, Hokusetsu General Hospital, Takatsuki, Osaka, Japan., Hoshiga M; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Takeuchi T; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Higuchi K; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan., Nishikawa H; Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686, Japan.

Publikováno v: BMC gastroenterology [BMC Gastroenterol] 2024 May 21; Vol. 24 (1), pp. 177. Date of Electronic Publication: 2024 May 21.

Clinical significance of aortic spontaneous echo contrast in patients with nonvalvular atrial fibrillation.

Autor: Hasegawa H; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Ito T; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Akamatsu K; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan., Hoshiga M; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.

Publikováno v: Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2024 Jan; Vol. 41 (1), pp. e15752.

Salivary Microbiota Associated with Peripheral Microvascular Endothelial Dysfunction.

Autor: Kato-Kogoe N; Department of Dentistry and Oral Surgery, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Kamiya K; Department of Hygiene and Public Health, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Sakaguchi S; Department of Microbiology and Infection Control, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Omori M; Department of Dentistry and Oral Surgery, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Komori E; Department of Dentistry and Oral Surgery, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Kudo A; Department of Hygiene and Public Health, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Nakamura S; Department of Infection Metagenomics, Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University., Nakano T; Department of Microbiology and Infection Control, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Ueno T; Department of Dentistry and Oral Surgery, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Tamaki J; Department of Hygiene and Public Health, Faculty of Medicine, Osaka Medical and Pharmaceutical University., Hoshiga M; Department of Cardiology, Faculty of Medicine, Osaka Medical and Pharmaceutical University.

Publikováno v: Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2023 Jul 01; Vol. 30 (7), pp. 820-833. Date of Electronic Publication: 2022 Sep 22.